Search Results Search Sort by RelevanceMost Recent State of the Art and Science Aug 2022 What Should Clinicians and Patients Know About the Clinical Gaze, Disability, and Iatrogenic Harm When Making Decisions? Chloë G. K. Atkins, PhD and Sunit Das, MD, PhD Avoiding harm requires that clinicians not overly rely on assumptions about “normal” embodiment. AMA J Ethics. 2022;24(8):E762-767. doi: 10.1001/amajethics.2022.762. State of the Art and Science Apr 2024 Which Data Analytics Tool Should We Use to Evaluate Risk in Upstream Drug Supply Chains? Matt Christian, MSc and Wejdan Bagais, MSc Drug shortages are persistent and serious in the US, affecting care quality and costs. An early warning system could help. AMA J Ethics. 2024;26(4):E306-314. doi: 10.1001/amajethics.2024.306.
State of the Art and Science Aug 2022 What Should Clinicians and Patients Know About the Clinical Gaze, Disability, and Iatrogenic Harm When Making Decisions? Chloë G. K. Atkins, PhD and Sunit Das, MD, PhD Avoiding harm requires that clinicians not overly rely on assumptions about “normal” embodiment. AMA J Ethics. 2022;24(8):E762-767. doi: 10.1001/amajethics.2022.762.
State of the Art and Science Apr 2024 Which Data Analytics Tool Should We Use to Evaluate Risk in Upstream Drug Supply Chains? Matt Christian, MSc and Wejdan Bagais, MSc Drug shortages are persistent and serious in the US, affecting care quality and costs. An early warning system could help. AMA J Ethics. 2024;26(4):E306-314. doi: 10.1001/amajethics.2024.306.